Vertex Pharmaceuticals
Vertex Pharmaceuticals's Overview
Vertex Pharmaceuticals is a global biotechnology company committed to the discovery, development, and commercialization of innovative medicines for people with serious and life-threatening diseases. With a primary focus on cystic fibrosis (CF), Vertex has developed multiple approved therapies that treat the underlying cause of CF for a significant portion of patients. Beyond CF, the company is advancing a robust pipeline of investigational therapies in other serious diseases, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, and alpha-1 antitrypsin deficiency. Vertex is recognized for its scientific rigor, patient-centric approach, and culture of innovation.
Where is Vertex Pharmaceuticals's Headquarters?
HQ Function
The Boston headquarters serves as the nerve center for Vertex's global operations, including executive leadership, corporate strategy, worldwide research and development direction, and key administrative functions.
Notable Features:
The campus features multiple state-of-the-art buildings with advanced research laboratories, collaborative workspaces, employee amenities, and sustainable design. Its location offers panoramic views of the Boston Harbor and city skyline.
Work Culture:
Vertex's headquarters fosters a high-performance, innovative, and collaborative work environment. The culture is deeply rooted in scientific excellence and a shared mission to transform the lives of patients with serious diseases. Employees often describe it as fast-paced and mission-driven.
HQ Significance:
Located in one of the world's foremost biotechnology clusters, the Boston headquarters allows Vertex to tap into a rich ecosystem of academic institutions, research talent, and partner companies, fostering innovation and growth.
Values Reflected in HQ: The headquarters' design and functionality reflect Vertex's core values: unwavering commitment to patients, innovation through cutting-edge science, and collaboration to achieve breakthroughs.
Location:
Vertex Pharmaceuticals maintains a significant global footprint to support its mission. Key functions distributed internationally include research and development (North America, Europe), clinical trial operations across numerous countries, manufacturing (primarily in North America), and commercial operations with offices in North America, Europe, Australia, and Latin America. This widespread presence enables Vertex to conduct global clinical studies, engage with regulatory authorities worldwide, and deliver its medicines to patients in over 30 countries.
Street Address:
50 Northern Avenue
City:
Boston
State/Province:
Massachusetts
Country:
USA
Vertex Pharmaceuticals's Global Presence
London, United Kingdom
Address: 2 Kingdom Street, Paddington Central, London, W2 6BD, UK
To expand patient access to Vertex's medicines and manage clinical and commercial activities outside of North America, ensuring global reach and impact.
San Diego, California, USA
Address: 3215 Merryfield Row, San Diego, CA 92121, USA
To drive scientific innovation and expand Vertex's pipeline through cutting-edge research, particularly in new and emerging disease areas.
Providence, Rhode Island, USA
Address: 100 Technology Way, Providence, RI 02903, USA
To advance the development and manufacturing of potentially curative cell-based therapies, particularly for type 1 diabetes.
Oxford, United Kingdom
Address: Milton Park, Abingdon, Oxfordshire, OX14 4RY, UK
To bolster Vertex's research capabilities in Europe and collaborate with the local scientific community to accelerate drug discovery.
Buying Intent Signals for Vertex Pharmaceuticals
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Vertex Pharmaceuticals
As of April 2025, Vertex Pharmaceuticals' leadership includes:
Investors of Vertex Pharmaceuticals
Vertex Pharmaceuticals has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the last 12 months (mid-2023 to mid-2024), Vertex Pharmaceuticals saw a key transition in its financial leadership with the appointment of a new Chief Accounting Officer. The core C-suite executive team has otherwise demonstrated stability, maintaining consistent leadership in its strategic pursuits.
Departures
New Appointments:
Technology (Tech Stack) used by Vertex Pharmaceuticals
Discover the tools Vertex Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Vertex Pharmaceuticals Email Formats and Examples
Vertex Pharmaceuticals typically utilizes standard corporate email formats, most commonly combining the employee's first initial and last name, or first name and last name separated by an underscore, followed by the @vrtx.com domain.
[first_initial][last_name]@vrtx.com or [first_name]_[last_name]@vrtx.com
Format
jdoe@vrtx.com or john_doe@vrtx.com
Example
90%
Success rate
News and media
Vertex Pharmaceuticals • May 29, 2024
Vertex Pharmaceuticals News: U.S. FDA Grants Fast Track Designation for VX-407 for the Treatment of APOL1-Mediated Focal Segmental Glomerulosclerosis
Vertex announced the U.S. Food and Drug Administration (FDA) granted Fast Track Designation for VX-407, an investigational small molecule corrector, for the treatment of APOL1-mediated focal segmental glomerulosclerosis (FSGS). This designation is intended to facilitate development and expedite review of new therapies for serious conditions....more
Vertex Pharmaceuticals • May 6, 2024
Vertex Pharmaceuticals Reports First Quarter 2024 Financial Results
Vertex announced its financial results for the first quarter of 2024, reporting total product revenues of $2.69 billion, a 13% increase compared to the first quarter of 2023. The company highlighted strong performance of its cystic fibrosis franchise and advancements in its pipeline....more
Vertex Pharmaceuticals • April 16, 2024
Vertex Pharmaceuticals News: FDA Advisory Committee Votes Favorably on Benefit/Risk Profile of Exagamglogene Autotemcel (exa-cel) for People With Transfusion-Dependent Beta Thalassemia
Vertex and CRISPR Therapeutics announced that the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee voted 10 to 0, with 1 abstention, that exagamglogene autotemcel (exa-cel) has a favorable benefit/risk profile for the treatment of people with transfusion-dependent beta thalassemia (TDT) who have a β0/β0 genotype or other genotypes that result in a similar severe phenotype. Exa-cel is marketed as CASGEVY™....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Vertex Pharmaceuticals, are just a search away.